10 completed, 3 unknown, 2 not yet recruiting, 2 recruiting. 20 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 20 | Completed 10, Unknown 3, Not yet recruiting 2, Recruiting 2, Terminated 2, Active not recruiting 1 |
Follow Vector Borne Diseases: new trials by email Literature Review of Vector Borne Diseases trials Research Report on Vector Borne Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study of PepGNP-ChikV in Healthy Volunteers PepGNP-ChikV, Placebo - Chikungunya, Chikungunya Fever | Early Phase 1 | Not yet recruiting | Gylden Pharma Ltd | 40 | 2026-08-03 | 2026-04-29 |
| Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy Dihydroartemisinin Piperaquine - Malaria Prevention | Early Phase 1 | Recruiting | University of North Carolina, Chapel Hill | 300 | 2026-04-22 | 2026-11-03 |
| Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune) rDEN2Δ30-7169 - Safety Issues, Dengue | Early Phase 1 | Not yet recruiting | Mahidol University | 12 | 2025-09-01 | 2025-04-03 |
| Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers Vaccine - Dengue | Early Phase 1 | Completed | Prince of Songkla University | 29 | 2025-04-19 | 2026-10-02 |
| Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease Ceftriaxone (Rocephin®), Dextrose 5% (D5W) - Post-Treatment Lyme Disease | Early Phase 1 | Recruiting | State University of New York - Upstate Medical University | 44 | 2025-02-03 | 2026-03-19 |
| Coadministration of GA2 Sporozoites With Adjuvants GA2, BCG, YF-17D (fractional ID dose) - Malaria,Falciparum | Early Phase 1 | Unknown | Leiden University Medical Center | 45 | 2023-02-03 | 2023-02-10 |
| A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults Matrix M with R78C and/or RH5.1 - Malaria, Falciparum | Early Phase 1 | Active not recruiting | University of Oxford | 36 | 2023-01-13 | 2025-04-01 |
| A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK Pfs48/45 in Matrix-M - Malaria, Plasmodium Falciparum | Early Phase 1 | Terminated | University of Oxford | 17 | 2022-11-02 | 2026-08-07 |
| Safety, Virological and Immunological Assessment of Live Attenuated Dengue Serotype 2 rDEN2delta30-7169. rDEN2Δ30-7169 - Dengue | Early Phase 1 | Unknown | Mahidol University | 5 | 2022-08-01 | 2022-07-27 |
| Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine Pvs25-IMX313/Matrix-M1 - Malaria, Vivax | Early Phase 1 | Terminated | University of Oxford | 25 | 2022-02-09 | 2026-01-15 |
| Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001) ChAdOx1 RVF - Rift Valley Fever | Early Phase 1 | Completed | University of Oxford | 15 | 2021-06-11 | 2023-05-19 |
| VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection P. vivax infected inoculum (parasitised red blood cells) - Malaria, Vivax | Early Phase 1 | Completed | University of Oxford | 19 | 2019-01-10 | 2025-04-25 |
| Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds WR826647, WR909388, WR909390 - Malaria | Early Phase 1 | Completed | U.S. Army Medical Research and Development Command | 18 | 2018-08-10 | 2019-03-05 |
| Resistance Exercise Program on the Functionality of Individuals With Chikungunya Fever Resistance exercise - Chikungunya Fever | Early Phase 1 | Unknown | Universidade Federal de Pernambuco | 30 | 2018-07-23 | 2019-09-27 |
| Effects of Omega-3 Supplementation on the Cytokine and Lipid Profiles in Patients With Chronic Chagas Cardiomyopathy Omega-3, Placebo Comparator - Chagas Cardiomyopathy | Early Phase 1 | Completed | Evandro Chagas Institute of Clinical Research | 40 | 2013-03-01 | 2016-09-09 |
| Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis Liposomal meglumine antimoniate (Glucantime), Liposomal meglumine antimoniate, Liposomal Paromomycin - Cutaneous Leishmaniasis | Early Phase 1 | Completed | Tehran University of Medical Sciences | 30 | 2011-03-01 | 2012-06-20 |
| Searching for Persistence of Infection in Lyme Disease Lyme Disease Xenodiagnosis - Lyme Disease | Early Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2010-11-04 | 2026-10-16 |
| Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART Lamivudine, Lopinavir/Ritonavir, Nevirapine - HIV Infections, Malaria | Early Phase 1 | Completed | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 105 | 2009-08-01 | 2016-09-19 |
| Study of Iron Absorption and Utilization in Asymptomatic Malaria Antimalarial treatment, Observation - Malaria, Falciparum | Early Phase 1 | Completed | Swiss Federal Institute of Technology | 23 | 2009-02-01 | 2013-06-07 |
| Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers Sporozoite Challenge Model for Plasmodium vivax in Humans - Malaria, Vivax | Early Phase 1 | Completed | Malaria Vaccine and Drug Development Center | 18 | 2005-01-01 | 2010-03-09 |
Malaria (6) · Malaria, Falciparum (4) · Dengue (3) · Malaria, Vivax (3) · Chikungunya Fever (2) · Chagas Cardiomyopathy (1) · Chagas Disease (1) · Coinfection (1) · Communicable Diseases (1) · HIV Infections (1) · Leishmaniasis, Cutaneous (1) · Lyme Disease (1) · Post-Lyme Disease Syndrome (1) · Rift Valley Fever (1) · Viremia (1)
Infections (20) · Mosquito-Borne Diseases (16) · Parasitic Diseases (12) · Protozoan Infections (12) · RNA Virus Infections (7) · Virus Diseases (7) · Arbovirus Infections (6) · Hemorrhagic Fevers, Viral (4) · Malaria (4) · Flaviviridae Infections (3) · Flavivirus Infections (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Alphavirus Infections (2)
Matrix-M (3) · Ceftriaxone (1) · Corn Oil (1) · Docosahexaenoic Acids (1) · Fatty Acids, Omega-3 (1) · Fatty Acids, Unsaturated (1) · Fish Oils (1) · Glucose (1) · Imiquimod (1) · Lamivudine (1) · Lopinavir (1) · Meglumine Antimoniate (1) · Nevirapine (1) · Observation (1) · Resistance Training (1)
University of Oxford (5) · Mahidol University (2) · Evandro Chagas Institute of Clinical Research (1) · Gylden Pharma Ltd (1) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1) · Leiden University Medical Center (1) · Malaria Vaccine and Drug Development Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Prince of Songkla University (1) · State University of New York - Upstate Medical University (1) · Swiss Federal Institute of Technology (1) · Tehran University of Medical Sciences (1) · U.S. Army Medical Research and Development Command (1) · Universidade Federal de Pernambuco (1) · University of North Carolina, Chapel Hill (1)
United Kingdom (5) · United States (3) · Brazil (2) · Thailand (2) · Uganda (2) · Benin (1) · Colombia (1) · Iran (1) · Malawi (1) · Netherlands (1) · Zambia (1)
Angela M Minassian, DPhil FRCP (3) · Adrian VS Hill, Prof (1) · Adriana R Marques, M.D. (1) · Ali Khamesipour, MPH, PhD (1) · Allen Hunt, MD (1) · Andrea S Sousa, MD PhD (1) · Angela M Minassian, MBBS MA DPhil MRCP FRCPath (1) · Charlotte Hobbs, MD (1) · Kristopher Paolino, MD (1) · Mahmoud Reza Jaafari, Parm D, PhD (1) · Masud Maleki, MD (1) · Meta Roestenberg, MD, PhD (1) · Michael Zimmermann, Prof., MD (1) · Ross Boyce, MD (1) · Socrates Herrera, MD (1)
PMID 11716100, PMID 11741694, PMID 11816444, PMID 12171615, PMID 12476490, PMID 13356045, PMID 14579464, PMID 14582335, PMID 1688828, PMID 20926522, PMID 2094597, PMID 24216069, PMID 24523212, PMID 27936233, PMID 28599665, PMID 34609964, PMID 3511753, PMID 35664997, PMID 37060917, PMID 37616070, PMID 39753962, PMID 40998768, PMID 4590095, PMID 7475658, PMID 7660433, PMID 7785527, PMID 7845714, PMID 7932927, PMID 808142, PMID 8357078, PMID 8376823, PMID 8842108, PMID 9086149, PMID 9192643, PMID 9797827
R21AI180728 (1), U01AI068632 (1)